Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
0.6%
1w
1.1%
1m
4.1%
3m
15.5%
6m
8.5%
1y
17.7%
all
17.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,180 0.6%
2,130
2,670
Company Overview

Sales
13,577 Cr
Growth: 20.1%
Profit after Tax
1,751 Cr
Growth: -7.5%
Large Cap
89,973 Cr
P/E: 51.0x
Industry P/E: 33.1x
Fundamentals

Sales (Cr) ₹ 13,577
Growth 20.1%
EBITDA 24.2%
P/S 6.6x
Dividend 0.0%
P/E 51.0x
Book Value ₹ 370
PEG Ratio 2.5x
ROE 12.7%
P/B 5.9x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)